相关实验视频
Updated: Sep 13, 2025

04:08
Metacarpal Small Incision for Carpal Tunnel Syndrome
Published on: April 5, 2024
633
在手腕道释放手术后心力衰竭的发生率
Harrison S Fellheimer1, Mahaa Ayub1, Gabriel I Onor2
1Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA.
Journal of hand surgery global online
|July 29, 2025
概括
手腕道释放手术增加了心力衰竭的风险. 接受手腕道手术的患者心力衰竭的发病率高于没有手术的患者.
科学领域:
- 心脏病学 心脏病学
- 神经学 神经学
- 外科手术的结果
背景情况:
- 之前的研究表明,手掌道综合征 (CTS) 和心力衰竭 (HF) 之间存在联系.
- 粉样蛋白沉积在CTS中可能会先于粉样蛋白心肌病变.
- 在CTS和HF之间存在潜在的产物关系,需要进行调查.
研究的目的:
- 调查一下手腕道释放手术的患者患心力衰竭的风险增加的假设.
- 为了比较手腕道手术的患者与没有手腕道手术的患者中HF的发病率.
主要方法:
- 利用TrinetX数据库来识别患有手腕道综合征 (CTS) 的患者.
- 包括接受手术治疗 (内镜或开放的手足道释放) 的患者.
- 倾向性得分匹配调整为人口统计和并发症;主要结局是心力衰竭 (HF).
主要成果:
- 在手腕道释放后的患者中,HF的发病率在5年后为3.49%,在20年后增加到7.102%.
- 手术患者在手术后五年 (P < .0001) 显示出对HF (1.129) 的统计学上显著增加的风险比率 (RR).
- 在20年内,HF风险差异达到2.007%,与非手术对照相比,RR为1.369.
结论:
- 与匹配的非手术对照组相比,接受手腕道释放手术的患者患心力衰竭的可能性明显更高.
- 该研究强调了CTS和HF之间的相关性增加,超过了一般人口的比例.
- 手部外科医生在早期识别CTS患者的HF风险方面发挥着至关重要的作用,促使进行心血管评估.
相关概念视频
Cardiac Catheterization I: Pre-Procedure Overview
160
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
160
Cardiac Catheterization IV: Nursing Management
193
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
193
Peripheral Artery Disease V: Postoperative Nursing Management
25
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
25
Cardiomyopathy VII: Pre and Post Operative Nursing Management
28
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
28
Cardiac Catheterization II: Right Heart Catheterization
166
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
166
Cardiomyopathy III: Hypertrophic Cardiomyopathy
52
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
52

